img

Global Drug Eluting Stents(DES) Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 282 | Industry : Medical Devices & Consumables

Publisher : MRA | Format : PDF

Global Drug Eluting Stents(DES) Sales Market Report 2024

The global Drug Eluting Stents(DES) market is segmented by company, region (country), by Materials, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Stents(DES) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Materials and by Application for the period 2016-2027.

Segment by Materials
Cobalt-chromium Alloy Stents
Magnesium Alloy Stents
Tyrosine Polycarbonate Stents
Nitinol Stents
Platinum Chromium Alloy Stents
Stainless Steel Stents
Other Materials


Segment by Application


Coronary Heart Disease
Clinical

The Drug Eluting Stents(DES) market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Drug Eluting Stents(DES) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical

Table of Content

1 Drug Eluting Stents(DES) Market Overview
1.1 Drug Eluting Stents(DES) Product Scope
1.2 Drug Eluting Stents(DES) Segment by Materials
1.2.1 Global Drug Eluting Stents(DES) Sales by Materials (2016 & 2021 & 2027)
1.2.2 Cobalt-chromium Alloy Stents
1.2.3 Magnesium Alloy Stents
1.2.4 Tyrosine Polycarbonate Stents
1.2.5 Nitinol Stents
1.2.6 Platinum Chromium Alloy Stents
1.2.7 Stainless Steel Stents
1.2.8 Other Materials
1.3 Drug Eluting Stents(DES) Segment by Application
1.3.1 Global Drug Eluting Stents(DES) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Coronary Heart Disease
1.3.3 Clinical
1.4 Drug Eluting Stents(DES) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Drug Eluting Stents(DES) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Drug Eluting Stents(DES) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Drug Eluting Stents(DES) Price Trends (2016-2027)

2 Drug Eluting Stents(DES) Estimates and Forecasts by Region
2.1 Global Drug Eluting Stents(DES) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Drug Eluting Stents(DES) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Drug Eluting Stents(DES) Sales Market Share by Region (2016-2021)
2.2.2 Global Drug Eluting Stents(DES) Revenue Market Share by Region (2016-2021)
2.3 Global Drug Eluting Stents(DES) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Drug Eluting Stents(DES) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Drug Eluting Stents(DES) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Drug Eluting Stents(DES) Estimates and Projections (2016-2027)
2.4.2 Europe Drug Eluting Stents(DES) Estimates and Projections (2016-2027)
2.4.3 China Drug Eluting Stents(DES) Estimates and Projections (2016-2027)
2.4.4 Japan Drug Eluting Stents(DES) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Drug Eluting Stents(DES) Estimates and Projections (2016-2027)
2.4.6 India Drug Eluting Stents(DES) Estimates and Projections (2016-2027)

3 Global Drug Eluting Stents(DES) Competition Landscape by Players
3.1 Global Top Drug Eluting Stents(DES) Players by Sales (2016-2021)
3.2 Global Top Drug Eluting Stents(DES) Players by Revenue (2016-2021)
3.3 Global Drug Eluting Stents(DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Eluting Stents(DES) as of 2020)
3.4 Global Drug Eluting Stents(DES) Average Price by Company (2016-2021)
3.5 Manufacturers Drug Eluting Stents(DES) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Drug Eluting Stents(DES) Market Size by Materials
4.1 Global Drug Eluting Stents(DES) Historic Market Review by Materials (2016-2021)
4.1.1 Global Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
4.1.2 Global Drug Eluting Stents(DES) Revenue Market Share by Materials (2016-2021)
4.1.3 Global Drug Eluting Stents(DES) Price by Materials (2016-2021)
4.2 Global Drug Eluting Stents(DES) Market Estimates and Forecasts by Materials (2022-2027)
4.2.1 Global Drug Eluting Stents(DES) Sales Forecast by Materials (2022-2027)
4.2.2 Global Drug Eluting Stents(DES) Revenue Forecast by Materials (2022-2027)
4.2.3 Global Drug Eluting Stents(DES) Price Forecast by Materials (2022-2027)

5 Global Drug Eluting Stents(DES) Market Size by Application
5.1 Global Drug Eluting Stents(DES) Historic Market Review by Application (2016-2021)
5.1.1 Global Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
5.1.2 Global Drug Eluting Stents(DES) Revenue Market Share by Application (2016-2021)
5.1.3 Global Drug Eluting Stents(DES) Price by Application (2016-2021)
5.2 Global Drug Eluting Stents(DES) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Drug Eluting Stents(DES) Sales Forecast by Application (2022-2027)
5.2.2 Global Drug Eluting Stents(DES) Revenue Forecast by Application (2022-2027)
5.2.3 Global Drug Eluting Stents(DES) Price Forecast by Application (2022-2027)

6 North America Drug Eluting Stents(DES) Market Facts & Figures
6.1 North America Drug Eluting Stents(DES) Sales by Company
6.1.1 North America Drug Eluting Stents(DES) Sales by Company (2016-2021)
6.1.2 North America Drug Eluting Stents(DES) Revenue by Company (2016-2021)
6.2 North America Drug Eluting Stents(DES) Sales Breakdown by Materials
6.2.1 North America Drug Eluting Stents(DES) Sales Breakdown by Materials (2016-2021)
6.2.2 North America Drug Eluting Stents(DES) Sales Breakdown by Materials (2022-2027)
6.3 North America Drug Eluting Stents(DES) Sales Breakdown by Application
6.3.1 North America Drug Eluting Stents(DES) Sales Breakdown by Application (2016-2021)
6.3.2 North America Drug Eluting Stents(DES) Sales Breakdown by Application (2022-2027)

7 Europe Drug Eluting Stents(DES) Market Facts & Figures
7.1 Europe Drug Eluting Stents(DES) Sales by Company
7.1.1 Europe Drug Eluting Stents(DES) Sales by Company (2016-2021)
7.1.2 Europe Drug Eluting Stents(DES) Revenue by Company (2016-2021)
7.2 Europe Drug Eluting Stents(DES) Sales Breakdown by Materials
7.2.1 Europe Drug Eluting Stents(DES) Sales Breakdown by Materials (2016-2021)
7.2.2 Europe Drug Eluting Stents(DES) Sales Breakdown by Materials (2022-2027)
7.3 Europe Drug Eluting Stents(DES) Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)

8 China Drug Eluting Stents(DES) Market Facts & Figures
8.1 China Drug Eluting Stents(DES) Sales by Company
8.1.1 China Drug Eluting Stents(DES) Sales by Company (2016-2021)
8.1.2 China Drug Eluting Stents(DES) Revenue by Company (2016-2021)
8.2 China Drug Eluting Stents(DES) Sales Breakdown by Materials
8.2.1 China Drug Eluting Stents(DES) Sales Breakdown by Materials (2016-2021)
8.2.2 China Drug Eluting Stents(DES) Sales Breakdown by Materials (2022-2027)
8.3 China Drug Eluting Stents(DES) Sales Breakdown by Application
8.3.1 China 176 Sales Breakdown by Application (2016-2021)
8.3.2 China 176 Sales Breakdown by Application (2022-2027)

9 Japan Drug Eluting Stents(DES) Market Facts & Figures
9.1 Japan Drug Eluting Stents(DES) Sales by Company
9.1.1 Japan Drug Eluting Stents(DES) Sales by Company (2016-2021)
9.1.2 Japan Drug Eluting Stents(DES) Revenue by Company (2016-2021)
9.2 Japan Drug Eluting Stents(DES) Sales Breakdown by Materials
9.2.1 Japan Drug Eluting Stents(DES) Sales Breakdown by Materials (2016-2021)
9.2.2 Japan Drug Eluting Stents(DES) Sales Breakdown by Materials (2022-2027)
9.3 Japan Drug Eluting Stents(DES) Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Drug Eluting Stents(DES) Market Facts & Figures
10.1 Southeast Asia Drug Eluting Stents(DES) Sales by Company
10.1.1 Southeast Asia Drug Eluting Stents(DES) Sales by Company (2016-2021)
10.1.2 Southeast Asia Drug Eluting Stents(DES) Revenue by Company (2016-2021)
10.2 Southeast Asia Drug Eluting Stents(DES) Sales Breakdown by Materials
10.2.1 Southeast Asia Drug Eluting Stents(DES) Sales Breakdown by Materials (2016-2021)
10.2.2 Southeast Asia Drug Eluting Stents(DES) Sales Breakdown by Materials (2022-2027)
10.3 Southeast Asia Drug Eluting Stents(DES) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Drug Eluting Stents(DES) Market Facts & Figures
11.1 India Drug Eluting Stents(DES) Sales by Company
11.1.1 India Drug Eluting Stents(DES) Sales by Company (2016-2021)
11.1.2 India Drug Eluting Stents(DES) Revenue by Company (2016-2021)
11.2 India Drug Eluting Stents(DES) Sales Breakdown by Materials
11.2.1 India Drug Eluting Stents(DES) Sales Breakdown by Materials (2016-2021)
11.2.2 India Drug Eluting Stents(DES) Sales Breakdown by Materials (2022-2027)
11.3 India Drug Eluting Stents(DES) Sales Breakdown by Application
11.3.1 India Drug Eluting Stents(DES) Sales Breakdown by Application (2016-2021)
11.3.2 India Drug Eluting Stents(DES) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Drug Eluting Stents(DES) Business
12.1 Abbott Vascular
12.1.1 Abbott Vascular Corporation Information
12.1.2 Abbott Vascular Business Overview
12.1.3 Abbott Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abbott Vascular Drug Eluting Stents(DES) Products Offered
12.1.5 Abbott Vascular Recent Development
12.2 Advantec Vascular
12.2.1 Advantec Vascular Corporation Information
12.2.2 Advantec Vascular Business Overview
12.2.3 Advantec Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Advantec Vascular Drug Eluting Stents(DES) Products Offered
12.2.5 Advantec Vascular Recent Development
12.3 B.Braun Melsengen AG
12.3.1 B.Braun Melsengen AG Corporation Information
12.3.2 B.Braun Melsengen AG Business Overview
12.3.3 B.Braun Melsengen AG Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 B.Braun Melsengen AG Drug Eluting Stents(DES) Products Offered
12.3.5 B.Braun Melsengen AG Recent Development
12.4 Biosensors
12.4.1 Biosensors Corporation Information
12.4.2 Biosensors Business Overview
12.4.3 Biosensors Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Biosensors Drug Eluting Stents(DES) Products Offered
12.4.5 Biosensors Recent Development
12.5 Biotronik
12.5.1 Biotronik Corporation Information
12.5.2 Biotronik Business Overview
12.5.3 Biotronik Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Biotronik Drug Eluting Stents(DES) Products Offered
12.5.5 Biotronik Recent Development
12.6 Blue Medical
12.6.1 Blue Medical Corporation Information
12.6.2 Blue Medical Business Overview
12.6.3 Blue Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Blue Medical Drug Eluting Stents(DES) Products Offered
12.6.5 Blue Medical Recent Development
12.7 Boston Scientific
12.7.1 Boston Scientific Corporation Information
12.7.2 Boston Scientific Business Overview
12.7.3 Boston Scientific Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Boston Scientific Drug Eluting Stents(DES) Products Offered
12.7.5 Boston Scientific Recent Development
12.8 DISA Vascular
12.8.1 DISA Vascular Corporation Information
12.8.2 DISA Vascular Business Overview
12.8.3 DISA Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 DISA Vascular Drug Eluting Stents(DES) Products Offered
12.8.5 DISA Vascular Recent Development
12.9 Essen
12.9.1 Essen Corporation Information
12.9.2 Essen Business Overview
12.9.3 Essen Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Essen Drug Eluting Stents(DES) Products Offered
12.9.5 Essen Recent Development
12.10 Medtronic Vascular
12.10.1 Medtronic Vascular Corporation Information
12.10.2 Medtronic Vascular Business Overview
12.10.3 Medtronic Vascular Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Medtronic Vascular Drug Eluting Stents(DES) Products Offered
12.10.5 Medtronic Vascular Recent Development
12.11 MicroPort Medical
12.11.1 MicroPort Medical Corporation Information
12.11.2 MicroPort Medical Business Overview
12.11.3 MicroPort Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 MicroPort Medical Drug Eluting Stents(DES) Products Offered
12.11.5 MicroPort Medical Recent Development
12.12 MIV Therapeutics
12.12.1 MIV Therapeutics Corporation Information
12.12.2 MIV Therapeutics Business Overview
12.12.3 MIV Therapeutics Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 MIV Therapeutics Drug Eluting Stents(DES) Products Offered
12.12.5 MIV Therapeutics Recent Development
12.13 Orbusneich
12.13.1 Orbusneich Corporation Information
12.13.2 Orbusneich Business Overview
12.13.3 Orbusneich Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Orbusneich Drug Eluting Stents(DES) Products Offered
12.13.5 Orbusneich Recent Development
12.14 Promed Medical
12.14.1 Promed Medical Corporation Information
12.14.2 Promed Medical Business Overview
12.14.3 Promed Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Promed Medical Drug Eluting Stents(DES) Products Offered
12.14.5 Promed Medical Recent Development
12.15 Relisys Medical
12.15.1 Relisys Medical Corporation Information
12.15.2 Relisys Medical Business Overview
12.15.3 Relisys Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Relisys Medical Drug Eluting Stents(DES) Products Offered
12.15.5 Relisys Medical Recent Development
12.16 Reva Medical
12.16.1 Reva Medical Corporation Information
12.16.2 Reva Medical Business Overview
12.16.3 Reva Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Reva Medical Drug Eluting Stents(DES) Products Offered
12.16.5 Reva Medical Recent Development
12.17 Sahajanand
12.17.1 Sahajanand Corporation Information
12.17.2 Sahajanand Business Overview
12.17.3 Sahajanand Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Sahajanand Drug Eluting Stents(DES) Products Offered
12.17.5 Sahajanand Recent Development
12.18 Sino Medical
12.18.1 Sino Medical Corporation Information
12.18.2 Sino Medical Business Overview
12.18.3 Sino Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Sino Medical Drug Eluting Stents(DES) Products Offered
12.18.5 Sino Medical Recent Development
12.19 Sorin
12.19.1 Sorin Corporation Information
12.19.2 Sorin Business Overview
12.19.3 Sorin Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Sorin Drug Eluting Stents(DES) Products Offered
12.19.5 Sorin Recent Development
12.20 Terumo Medical
12.20.1 Terumo Medical Corporation Information
12.20.2 Terumo Medical Business Overview
12.20.3 Terumo Medical Drug Eluting Stents(DES) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Terumo Medical Drug Eluting Stents(DES) Products Offered
12.20.5 Terumo Medical Recent Development

13 Drug Eluting Stents(DES) Manufacturing Cost Analysis
13.1 Drug Eluting Stents(DES) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Drug Eluting Stents(DES)
13.4 Drug Eluting Stents(DES) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Drug Eluting Stents(DES) Distributors List
14.3 Drug Eluting Stents(DES) Customers

15 Market Dynamics
15.1 Drug Eluting Stents(DES) Market Trends
15.2 Drug Eluting Stents(DES) Drivers
15.3 Drug Eluting Stents(DES) Market Challenges
15.4 Drug Eluting Stents(DES) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Drug Eluting Stents(DES) Sales (US$ Million) Growth Rate by Materials (2016 & 2021 & 2027)
Table 2. Global Drug Eluting Stents(DES) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Drug Eluting Stents(DES) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Drug Eluting Stents(DES) Sales (K Units) by Region (2016-2021)
Table 5. Global Drug Eluting Stents(DES) Sales Market Share by Region (2016-2021)
Table 6. Global Drug Eluting Stents(DES) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Drug Eluting Stents(DES) Revenue Share by Region (2016-2021)
Table 8. Global Drug Eluting Stents(DES) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Drug Eluting Stents(DES) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Drug Eluting Stents(DES) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Drug Eluting Stents(DES) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Drug Eluting Stents(DES) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Drug Eluting Stents(DES) Sales Share by Company (2016-2021)
Table 14. Global Drug Eluting Stents(DES) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Drug Eluting Stents(DES) Revenue Share by Company (2016-2021)
Table 16. Global Drug Eluting Stents(DES) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Stents(DES) as of 2020)
Table 17. Global Drug Eluting Stents(DES) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Drug Eluting Stents(DES) Manufacturing Sites and Area Served
Table 19. Manufacturers Drug Eluting Stents(DES) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Drug Eluting Stents(DES) Sales (K Units) by Materials (2016-2021)
Table 22. Global Drug Eluting Stents(DES) Sales Share by Materials (2016-2021)
Table 23. Global Drug Eluting Stents(DES) Revenue (US$ Million) Market Share by Materials (2016-2021)
Table 24. Global Drug Eluting Stents(DES) Price (USD/Unit) by Materials (2016-2021)
Table 25. Global Drug Eluting Stents(DES) Sales Share by Materials (2022-2027)
Table 26. Global Drug Eluting Stents(DES) Revenue (US$ Million) Market Share by Materials (2022-2027)
Table 27. Global Drug Eluting Stents(DES) Revenue Share by Materials (2022-2027)
Table 28. Global Drug Eluting Stents(DES) Price (USD/Unit) by Materials (2022-2027)
Table 29. Global Drug Eluting Stents(DES) Sales (K Units) by Application (2016-2021)
Table 30. Global Drug Eluting Stents(DES) Sales Share by Application (2016-2021)
Table 31. Global Drug Eluting Stents(DES) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Drug Eluting Stents(DES) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Drug Eluting Stents(DES) Sales (K Units) by Application (2022-2027)
Table 34. Global Drug Eluting Stents(DES) Sales Share by Application (2022-2027)
Table 35. Global Drug Eluting Stents(DES) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Drug Eluting Stents(DES) Revenue Share by Application (2022-2027)
Table 37. Global Drug Eluting Stents(DES) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Drug Eluting Stents(DES) Sales (K Units) by Company (2016-2021)
Table 39. North America Drug Eluting Stents(DES) Sales Market Share by Company (2016-2021)
Table 40. North America Drug Eluting Stents(DES) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Drug Eluting Stents(DES) Revenue Market Share by Company (2016-2021)
Table 42. North America Drug Eluting Stents(DES) Sales by Materials (2016-2021) & (K Units)
Table 43. North America Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 44. North America Drug Eluting Stents(DES) Sales by Materials (2022-2027) & (K Units)
Table 45. North America Drug Eluting Stents(DES) Sales Market Share by Materials (2022-2027)
Table 46. North America Drug Eluting Stents(DES) Sales by Application (2016-2021) & (K Units)
Table 47. North America Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 48. North America Drug Eluting Stents(DES) Sales by Application (2022-2027) & (K Units)
Table 49. North America Drug Eluting Stents(DES) Sales Market Share by Application (2022-2027)
Table 50. Europe Drug Eluting Stents(DES) Sales (K Units) by Company (2016-2021)
Table 51. Europe Drug Eluting Stents(DES) Sales Market Share by Company (2016-2021)
Table 52. Europe Drug Eluting Stents(DES) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Drug Eluting Stents(DES) Revenue Market Share by Company (2016-2021)
Table 54. Europe Drug Eluting Stents(DES) Sales by Materials (2016-2021) & (K Units)
Table 55. Europe Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 56. Europe Drug Eluting Stents(DES) Sales by Materials (2022-2027) & (K Units)
Table 57. Europe Drug Eluting Stents(DES) Sales Market Share by Materials (2022-2027)
Table 58. Europe Drug Eluting Stents(DES) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 60. Europe Drug Eluting Stents(DES) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Drug Eluting Stents(DES) Sales Market Share by Application (2022-2027)
Table 62. China Drug Eluting Stents(DES) Sales (K Units) by Company (2016-2021)
Table 63. China Drug Eluting Stents(DES) Sales Market Share by Company (2016-2021)
Table 64. China Drug Eluting Stents(DES) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Drug Eluting Stents(DES) Revenue Market Share by Company (2016-2021)
Table 66. China Drug Eluting Stents(DES) Sales by Materials (2016-2021) & (K Units)
Table 67. China Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 68. China Drug Eluting Stents(DES) Sales by Materials (2022-2027) & (K Units)
Table 69. China Drug Eluting Stents(DES) Sales Market Share by Materials (2022-2027)
Table 70. China Drug Eluting Stents(DES) Sales by Application (2016-2021) & (K Units)
Table 71. China Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 72. China Drug Eluting Stents(DES) Sales by Application (2022-2027) & (K Units)
Table 73. China Drug Eluting Stents(DES) Sales Market Share by Application (2022-2027)
Table 74. Japan Drug Eluting Stents(DES) Sales (K Units) by Company (2016-2021)
Table 75. Japan Drug Eluting Stents(DES) Sales Market Share by Company (2016-2021)
Table 76. Japan Drug Eluting Stents(DES) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Drug Eluting Stents(DES) Revenue Market Share by Company (2016-2021)
Table 78. Japan Drug Eluting Stents(DES) Sales by Materials (2016-2021) & (K Units)
Table 79. Japan Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 80. Japan Drug Eluting Stents(DES) Sales by Materials (2022-2027) & (K Units)
Table 81. Japan Drug Eluting Stents(DES) Sales Market Share by Materials (2022-2027)
Table 82. Japan Drug Eluting Stents(DES) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 84. Japan Drug Eluting Stents(DES) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Drug Eluting Stents(DES) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Drug Eluting Stents(DES) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Drug Eluting Stents(DES) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Drug Eluting Stents(DES) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Drug Eluting Stents(DES) Sales by Materials (2016-2021) & (K Units)
Table 91. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 92. Southeast Asia Drug Eluting Stents(DES) Sales by Materials (2022-2027) & (K Units)
Table 93. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Materials (2022-2027)
Table 94. Southeast Asia Drug Eluting Stents(DES) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Drug Eluting Stents(DES) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Application (2022-2027)
Table 98. India Drug Eluting Stents(DES) Sales (K Units) by Company (2016-2021)
Table 99. India Drug Eluting Stents(DES) Sales Market Share by Company (2016-2021)
Table 100. India Drug Eluting Stents(DES) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Drug Eluting Stents(DES) Revenue Market Share by Company (2016-2021)
Table 102. India Drug Eluting Stents(DES) Sales by Materials (2016-2021) & (K Units)
Table 103. India Drug Eluting Stents(DES) Sales Market Share by Materials (2016-2021)
Table 104. India Drug Eluting Stents(DES) Sales by Materials (2022-2027) & (K Units)
Table 105. India Drug Eluting Stents(DES) Sales Market Share by Materials (2022-2027)
Table 106. India Drug Eluting Stents(DES) Sales by Application (2016-2021) & (K Units)
Table 107. India Drug Eluting Stents(DES) Sales Market Share by Application (2016-2021)
Table 108. India Drug Eluting Stents(DES) Sales by Application (2022-2027) & (K Units)
Table 109. India Drug Eluting Stents(DES) Sales Market Share by Application (2022-2027)
Table 110. Abbott Vascular Corporation Information
Table 111. Abbott Vascular Description and Business Overview
Table 112. Abbott Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Abbott Vascular Drug Eluting Stents(DES) Product
Table 114. Abbott Vascular Recent Development
Table 115. Advantec Vascular Corporation Information
Table 116. Advantec Vascular Description and Business Overview
Table 117. Advantec Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Advantec Vascular Drug Eluting Stents(DES) Product
Table 119. Advantec Vascular Recent Development
Table 120. B.Braun Melsengen AG Corporation Information
Table 121. B.Braun Melsengen AG Description and Business Overview
Table 122. B.Braun Melsengen AG Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. B.Braun Melsengen AG Drug Eluting Stents(DES) Product
Table 124. B.Braun Melsengen AG Recent Development
Table 125. Biosensors Corporation Information
Table 126. Biosensors Description and Business Overview
Table 127. Biosensors Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Biosensors Drug Eluting Stents(DES) Product
Table 129. Biosensors Recent Development
Table 130. Biotronik Corporation Information
Table 131. Biotronik Description and Business Overview
Table 132. Biotronik Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Biotronik Drug Eluting Stents(DES) Product
Table 134. Biotronik Recent Development
Table 135. Blue Medical Corporation Information
Table 136. Blue Medical Description and Business Overview
Table 137. Blue Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Blue Medical Drug Eluting Stents(DES) Product
Table 139. Blue Medical Recent Development
Table 140. Boston Scientific Corporation Information
Table 141. Boston Scientific Description and Business Overview
Table 142. Boston Scientific Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Boston Scientific Drug Eluting Stents(DES) Product
Table 144. Boston Scientific Recent Development
Table 145. DISA Vascular Corporation Information
Table 146. DISA Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. DISA Vascular Description and Business Overview
Table 148. DISA Vascular Drug Eluting Stents(DES) Product
Table 149. DISA Vascular Recent Development
Table 150. Essen Corporation Information
Table 151. Essen Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Essen Description and Business Overview
Table 153. Essen Drug Eluting Stents(DES) Product
Table 154. Essen Recent Development
Table 155. Medtronic Vascular Corporation Information
Table 156. Medtronic Vascular Description and Business Overview
Table 157. Medtronic Vascular Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Medtronic Vascular Drug Eluting Stents(DES) Product
Table 159. Medtronic Vascular Recent Development
Table 160. MicroPort Medical Corporation Information
Table 161. MicroPort Medical Description and Business Overview
Table 162. MicroPort Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. MicroPort Medical Drug Eluting Stents(DES) Product
Table 164. MicroPort Medical Recent Development
Table 165. MIV Therapeutics Corporation Information
Table 166. MIV Therapeutics Description and Business Overview
Table 167. MIV Therapeutics Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. MIV Therapeutics Drug Eluting Stents(DES) Product
Table 169. MIV Therapeutics Recent Development
Table 170. Orbusneich Corporation Information
Table 171. Orbusneich Description and Business Overview
Table 172. Orbusneich Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. Orbusneich Drug Eluting Stents(DES) Product
Table 174. Orbusneich Recent Development
Table 175. Promed Medical Corporation Information
Table 176. Promed Medical Description and Business Overview
Table 177. Promed Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 178. Promed Medical Drug Eluting Stents(DES) Product
Table 179. Promed Medical Recent Development
Table 180. Relisys Medical Corporation Information
Table 181. Relisys Medical Description and Business Overview
Table 182. Relisys Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 183. Relisys Medical Drug Eluting Stents(DES) Product
Table 184. Relisys Medical Recent Development
Table 185. Reva Medical Corporation Information
Table 186. Reva Medical Description and Business Overview
Table 187. Reva Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 188. Reva Medical Drug Eluting Stents(DES) Product
Table 189. Reva Medical Recent Development
Table 190. Sahajanand Corporation Information
Table 191. Sahajanand Description and Business Overview
Table 192. Sahajanand Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 193. Sahajanand Drug Eluting Stents(DES) Product
Table 194. Sahajanand Recent Development
Table 195. Sino Medical Corporation Information
Table 196. Sino Medical Description and Business Overview
Table 197. Sino Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 198. Sino Medical Drug Eluting Stents(DES) Product
Table 199. Sino Medical Recent Development
Table 200. Sorin Corporation Information
Table 201. Sorin Description and Business Overview
Table 202. Sorin Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 203. Sorin Drug Eluting Stents(DES) Product
Table 204. Sorin Recent Development
Table 205. Terumo Medical Corporation Information
Table 206. Terumo Medical Description and Business Overview
Table 207. Terumo Medical Drug Eluting Stents(DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 208. Terumo Medical Drug Eluting Stents(DES) Product
Table 209. Terumo Medical Recent Development
Table 210. Production Base and Market Concentration Rate of Raw Material
Table 211. Key Suppliers of Raw Materials
Table 212. Drug Eluting Stents(DES) Distributors List
Table 213. Drug Eluting Stents(DES) Customers List
Table 214. Drug Eluting Stents(DES) Market Trends
Table 215. Drug Eluting Stents(DES) Market Drivers
Table 216. Drug Eluting Stents(DES) Market Challenges
Table 217. Drug Eluting Stents(DES) Market Restraints
Table 218. Research Programs/Design for This Report
Table 219. Key Data Information from Secondary Sources
Table 220. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Eluting Stents(DES) Product Picture
Figure 2. Global Drug Eluting Stents(DES) Sales Market Share by Materials in 2021 & 2027
Figure 3. Cobalt-chromium Alloy Stents Product Picture
Figure 4. Magnesium Alloy Stents Product Picture
Figure 5. Tyrosine Polycarbonate Stents Product Picture
Figure 6. Nitinol Stents Product Picture
Figure 7. Platinum Chromium Alloy Stents Product Picture
Figure 8. Stainless Steel Stents Product Picture
Figure 9. Other Materials Product Picture
Figure 10. Global Drug Eluting Stents(DES) Sales Market Share by Application in 2021 & 2027
Figure 11. Coronary Heart Disease Examples
Figure 12. Clinical Examples
Figure 13. Global Drug Eluting Stents(DES) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Drug Eluting Stents(DES) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Drug Eluting Stents(DES) Sales (K Units) Growth Rate (2016-2027)
Figure 16. Global Drug Eluting Stents(DES) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 17. Global Drug Eluting Stents(DES) Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Drug Eluting Stents(DES) Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Drug Eluting Stents(DES) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Drug Eluting Stents(DES) Sales (K Units) Growth Rate (2016-2027)
Figure 21. Europe Drug Eluting Stents(DES) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Drug Eluting Stents(DES) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Drug Eluting Stents(DES) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Drug Eluting Stents(DES) Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Drug Eluting Stents(DES) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Drug Eluting Stents(DES) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Drug Eluting Stents(DES) Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Drug Eluting Stents(DES) Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Drug Eluting Stents(DES) Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Drug Eluting Stents(DES) Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Drug Eluting Stents(DES) Players Market Share by Revenue in Drug Eluting Stents(DES): 2016 & 2020
Figure 32. Drug Eluting Stents(DES) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Drug Eluting Stents(DES) Revenue Share by Materials (2016-2021)
Figure 34. Global Drug Eluting Stents(DES) Revenue Growth Rate by Materials in 2016 & 2020
Figure 35. Global Drug Eluting Stents(DES) Revenue Share by Application (2016-2021)
Figure 36. Global Drug Eluting Stents(DES) Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Drug Eluting Stents(DES) Sales Market Share by Materials in 2020
Figure 38. North America Drug Eluting Stents(DES) Sales Market Share by Application in 2020
Figure 39. Europe Drug Eluting Stents(DES) Sales Market Share by Materials in 2020
Figure 40. Europe Drug Eluting Stents(DES) Sales Market Share by Application in 2020
Figure 41. China Drug Eluting Stents(DES) Sales Market Share by Materials in 2020
Figure 42. China Drug Eluting Stents(DES) Sales Market Share by Application in 2020
Figure 43. Japan Drug Eluting Stents(DES) Sales Market Share by Materials in 2020
Figure 44. Japan Drug Eluting Stents(DES) Sales Market Share by Application in 2020
Figure 45. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Materials in 2020
Figure 46. Southeast Asia Drug Eluting Stents(DES) Sales Market Share by Application in 2020
Figure 47. India Drug Eluting Stents(DES) Sales Market Share by Materials in 2020
Figure 48. India Drug Eluting Stents(DES) Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Drug Eluting Stents(DES)
Figure 51. Manufacturing Process Analysis of Drug Eluting Stents(DES)
Figure 52. Drug Eluting Stents(DES) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed